- Home
- QNRX vs TTNP Comparison
QNRX vs TTNP Comparison
Compare QNRX & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- TTNP
- Stock Information
- Founded
- QNRX 2018
- TTNP 1991
- Country
- QNRX United States
- TTNP United States
- Employees
- QNRX 3
- TTNP N/A
- Industry
- QNRX Medical/Dental Instruments
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QNRX Health Care
- TTNP Health Care
- Exchange
- QNRX Nasdaq
- TTNP Nasdaq
- Market Cap
- QNRX 4.8M
- TTNP 5.4M
- IPO Year
- QNRX N/A
- TTNP 1996
- Fundamental
- Price
- QNRX $8.59
- TTNP $4.28
- Analyst Decision
- QNRX
- TTNP
- Analyst Count
- QNRX 0
- TTNP 0
- Target Price
- QNRX N/A
- TTNP N/A
- AVG Volume (30 Days)
- QNRX 107.3K
- TTNP 88.1K
- Earning Date
- QNRX 11-06-2025
- TTNP 08-14-2025
- Dividend Yield
- QNRX N/A
- TTNP N/A
- EPS Growth
- QNRX N/A
- TTNP N/A
- EPS
- QNRX N/A
- TTNP N/A
- Revenue
- QNRX N/A
- TTNP N/A
- Revenue This Year
- QNRX N/A
- TTNP N/A
- Revenue Next Year
- QNRX N/A
- TTNP N/A
- P/E Ratio
- QNRX N/A
- TTNP N/A
- Revenue Growth
- QNRX N/A
- TTNP N/A
- 52 Week Low
- QNRX $5.01
- TTNP $3.03
- 52 Week High
- QNRX $54.95
- TTNP $6.43
- Technical
- Relative Strength Index (RSI)
- QNRX 70.88
- TTNP 47.71
- Support Level
- QNRX $7.35
- TTNP $3.90
- Resistance Level
- QNRX $7.79
- TTNP $4.55
- Average True Range (ATR)
- QNRX 0.38
- TTNP 0.32
- MACD
- QNRX 0.13
- TTNP 0.00
- Stochastic Oscillator
- QNRX 46.79
- TTNP 66.04
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.